| | |
| 2808 | Effects of Propolis Dentifrice on Rat Periodontitis Model
D. EKUNI, R. YAMANAKA, T. SANBE, T. YAMAMOTO, and T. WATANABE, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan |
| 2809 | Oral health-related quality of life in patients with hypersensitive teeth
C. HIRSCH1, K. BEKES1, M.T. JOHN2, and H.-G. SCHALLER1, 1Martin-Luther-University Halle, Germany, 2University of Leipzig, Germany |
| 2810 | Low-resource screening of Pre-Cancerous Lesions and its reversal by Triphala
A. KOCHHAR, Manipal College of Dental Sciences, Manipal, India |
| 2812 | Cleaning Efficacy of Nine Interdental Brushes
D.J. HOFER, T. IMFELD, T. ATTIN, and P.R. SCHMIDLIN, University of Zurich, Switzerland |
| 2814 | Next generation non abrasive tooth cleaning gel
D. MORI, S. YAMAGUCHI, and M. TAKAYAMA, GC Corporation, Tokyo, Japan |
| 2815 | Gingivitis Suppression Effect of the Dentifrices Containing Curcuma Xanthorrhiza
S.-J. HWANG, B.-H. JIN, D.-I. PAIK, and H.-D. KIM, Seoul National University, South Korea |
| 2816 | Cystein protease reduces tongue coating and volatile sulfur compounds
K. NOHNO, T. YAMAGA, N. KANEKO, and H. MIYAZAKI, Graduate School of Medical and Dental Sciences Niigata University, Japan |
| 2818 | Development of an in-vitro whitening model
J. GORDON, and E. PATERSON, GlaxoSmithKline Consumer Healthcare, Weybridge, United Kingdom |
| 2819 | Breakdown of Hydrogen Peroxide Gel in the Mouth
E.E. NEWBY1, L.A. STOCKERT2, M.L. BOSMA1, M. NORTH1, and J. LIEBMAN3, 1GlaxoSmithKline, Weybridge, United Kingdom, 2GlaxoSmithKline, Parsipanny, NJ, USA, 3Hill Top Research, Inc, West Palm Beach, FL, USA |
| 2820 | Convenient culture kit to estimate individual S.mutans and S.sobrinus levels
K. MIZUNO1, T. IKEMI1, K. MONZAWA1, H. GOTOUDA1, S. KOBAYASHI1, Y. NISHIYAMA2, I. KANTAKE2, N. HANADA3, and K. FUKUSHIMA4, 1Nihon University, Chiba, Japan, 2Dental Support Co., Ltd, Chiba, Japan, 3National Institute of Public Health, Wako City, Japan, 4Nihon University School of Dentistry at Matsudo, Dental Support Co., Ltd., National Institute of Public Health, Chiba, Japan |
| 2821 | Oral Tolerability of Hydrogen Peroxide Whitening Gel Formulations
A. BORDAS1, M.P. BOSMA1, C.J. KLEBER2, K. MILLEMAN2, J. MILLEMAN2, N. SCHOBER3, and G. SHANGA3, 1GlaxoSmithKline, Weybridge, United Kingdom, 2University Park Research Center, Ft Wayne, IN, USA, 3GlaxoSmithKline, Parsippany, NJ, USA |
| 2822 | Caries expirience in children with disabilities compared to healthy children
V. FUGOSIC, D. BAKARCIC, V. MIKIC, N. IVANCIC JOKIC, and R. GRZIC, University of Rijeka, Medical Faculty, School of Dentistry, Croatia |
| 2823 | COX-2 -765G->C Polymorphisms and Oral Cancer Risk in Southern Taiwan
Y.-C. LIN1, H.-I. HUANG2, C.-C. TSAI1, and C.-H. CHEN1, 1Kaohsiung Medical University, Taiwan, 2Kaohsiung Medical College, Taiwan |
| 2824 | Enamel Safety Study of an Experimental Tooth Whitening Formulation
A. HUNT, GlaxoSmithKline Consumer Healthcare, Weybridge, United Kingdom, F. LIPPERT, GlaxoSmithKline, Weybridge, United Kingdom, and C. GONZALEZ-CABEZAS, University of Indiana Indianapolis, USA |
| 2825 | Safety and Efficacy of a 10% Hydrogen Peroxide Whitening Gel
L.A. STOCKERT, GlaxoSmithKline, Parsipanny, NJ, USA, K. BAROUTH, Dental Products Testing, West Palm Beach, FL, USA, M.L. BOSMA, GlaxoSmithKline, Weybridge, United Kingdom, and A. SELMANI, GlaxoSmithKline, Parsippany, NJ, USA |
| 2826 | Cultured Gingival Fibroblasts as a Model of Oral Mucosa Inflammation
R. RETI, University of Detroit Mercy, Windsor, Canada, M. WHEATER, University of Detroit Mercy, MI, USA, and G. SOSNE, Wayne State University School of Medicine, Detroit, MI, USA |
| 2827 | Enterococcus faecalis: Resistant Endodontic Pathogen not found in Oral Cultures
J.G. THOMAS1, L.A. NAKAISHI1, J.S. ELLIS1, and D. KEPNER2, 1West Virginia University, Morgantown, USA, 2Focus Bio-Inova Inc, Herndon, VA, USA |
|